Coleen Glessner - Apr 7, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Quality & Ethics, and CPL
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Apr 7, 2023
Transactions value $
$0
Form type
4
Date filed
4/10/2023, 07:41 PM
Previous filing
Mar 6, 2023
Next filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $0 +480 +0.4% $0.00 120K Apr 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.